GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $35,011,000 | -7.8% | 1,095,810 | 0.0% | 0.21% | +20.5% |
| Q1 2022 | $37,959,000 | +40.8% | 1,095,810 | +19.0% | 0.17% | +69.3% |
| Q4 2021 | $26,952,000 | -8.9% | 920,810 | -20.7% | 0.10% | -16.5% |
| Q3 2021 | $29,580,000 | +12.6% | 1,160,900 | +54.8% | 0.12% | +6.1% |
| Q2 2021 | $26,265,000 | -14.1% | 750,000 | 0.0% | 0.11% | -39.7% |
| Q1 2021 | $30,563,000 | +41.1% | 750,000 | +50.0% | 0.19% | +44.3% |
| Q4 2020 | $21,655,000 | – | 500,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |